Skip to main content
SpringerLink
Log in

Predictive Values of Postoperative and Dynamic Changes of Inflammation Indexes in Survival of Patients with Resected Colorectal Cancer

  • Published:
Current Medical Science Aims and scope Submit manuscript

Abstract

The aim of the present study was to evaluate the prognostic potential of postoperative scores of inflammation indexes and the dynamic changes of scores before and after tumor resection in colorectal cancer patients. The study included 516 colorectal cancer patients with primary colorectal tumor resection. Cox regression was applied to estimate the associations of postoperative and dynamic changes of inflammation indexes with progression-free survival and overall survival. As results, we found that higher postoperative neutrophil to lymphocyte ratio (NLR), neutrophil and monocyte to lymphocyte ratio (NMLR), platelet to lymphocyte ratio (PLR) and systemic immune inflammation index (SII) were associated with shorter progression-free survival. The increased NLR, NMLR, PLR, SII and C-reaction protein (CRP) to albumin (ALB) ratio (CAR) were associated with poor progression-free survival, with HRs (95% CIs) of 1.92 (1.27–2.90), 1.46 (1.11–2.09), 2.10 (1.34–3.30), 1.81 (1.22–2.70) and 1.65 (1.03–2.67), respectively. Postoperative NMLR, SII, CAR, and their dynamic changes were also significantly correlated with overall survival, with the HRs (95% CIs) of 2.63 (1.30–3.97), 2.44 (1.43–4.17), 2.74 (1.31–5.74), 2.08 (1.21–3.60), 1.97 (1.12–3.45) and 2.55 (1.21–5.38) respectively. In conclusion, postoperative inflammation indexes and their dynamic changes, particularly for NMLR, SII and CAR are promising prognostic predictors of CRC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015,136(5):E359–386

    Article  CAS  Google Scholar 

  2. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet, 2014,383(9927):1490–1502

    Article  PubMed  Google Scholar 

  3. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin, 2012,62(4):220–241

    Article  PubMed  Google Scholar 

  4. Hu H, Krasinskas A, Willis J. Perspectives on current tumor-node-metastasis (TNM) staging of cancers of the colon and rectum. Semin Oncol, 2011,38(4):500–510

    Article  PubMed  Google Scholar 

  5. Stintzing S, Stremitzer S, Sebio A, et al. Predictive and prognostic markers in the treatment of metastatic colorectal cancer (mCRC): personalized medicine at work. Hematol Oncol Clin North Am, 2015,29(1):43–60

    Article  PubMed  Google Scholar 

  6. Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol, 2010,6(1):149–163

    Article  CAS  PubMed  Google Scholar 

  7. Park JH, Watt DG, Roxburgh CS, et al. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host. Ann Surg, 2016,263(2):326–336

    Article  PubMed  Google Scholar 

  8. Watt DG, McSorley ST, Park JH, et al. A Postoperative Systemic Inflammation Score Predicts Short-and Long-Term Outcomes in Patients Undergoing Surgery for Colorectal Cancer. Ann Surg Oncol, 2017,24(4):1100–1109

    Article  PubMed  Google Scholar 

  9. Tominaga T, Nonaka T, Sumida Y, et al. The C-Reactive Protein to Albumin Ratio as a Predictor of Severe Side Effects of Adjuvant Chemotherapy in Stage III Colorectal Cancer Patients. PLoS One, 2016,11(12):e0167967

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Yamamura K, Sugimoto H, Kanda M, et al. Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection. J Hepatobiliary Pancreat Sci, 2014,21(9):682–688

    Article  PubMed  Google Scholar 

  11. Zou ZY, Liu HL, Ning N, et al. Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer. Oncol Lett, 2016,11(3):2241–2248

    Article  PubMed  PubMed Central  Google Scholar 

  12. Song W, Wang K, Zhang RJ, et al. Prognostic value of the lymphocyte monocyte ratio in patients with colorectal cancer: A meta-analysis. Medicine, 2016,95(49):e5540

    Article  PubMed  PubMed Central  Google Scholar 

  13. Yang Y, Gao P, Chen X, et al. Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a retrospective cohort study and a meta-analysis. Oncotarget, 2016,7(36):58543–58552

    PubMed  PubMed Central  Google Scholar 

  14. Liao R, Jiang N, Tang ZW, et al. Systemic and intratumoral balances between monocytes/macrophages and lymphocytes predict prognosis in hepatocellular carcinoma patients after surgery. Oncotarget, 2016,7(21):30951–30961

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hong X, Cui B, Wang M, et al. Systemic Immuneinflammation Index, Based on Platelet Counts and Neutrophil-Lymphocyte Ratio, Is Useful for Predicting Prognosis in Small Cell Lung Cancer. Tohoku J Exp Med, 2015,236(4):297–304

    Article  CAS  PubMed  Google Scholar 

  16. Hamilton Stanley R, Lauri A, et al. Pathology and genetics of tumours of the digestive system. Histopathology, 2010,38(6):585–585

    Google Scholar 

  17. Brown G, Radcliffe AG, Newcombe RG, et al. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg, 2003,90(3):355–364

    Article  CAS  Google Scholar 

  18. Jin F, Han A, Shi F, et al. The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer. Onco Targets Ther, 2016,9:6529–6537

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Pang S, Zhou Z, Yu X, et al. The predictive value of integrated inflammation scores in the survival of patients with resected hepatocellular carcinoma: A Retrospective Cohort Study. Int J Surg, 2017,42:170–177

    Article  PubMed  Google Scholar 

  20. Harrell FE Jr, Califf RM, Pryor DB, et al. Evaluating the yield of medical tests. JAMA, 1982,247:2543–2546

    Article  PubMed  Google Scholar 

  21. Josa V, Krzystanek M, Eklund AC, et al. Relationship of postoperative thrombocytosis and survival of patients with colorectal cancer. Int J Surg, 2015,18:1–6

    Article  PubMed  Google Scholar 

  22. Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity, 2004, 21(2): 137–148

    Article  CAS  PubMed  Google Scholar 

  23. Titu LV, Monson JR, Greenman J. The role of CD8(+) T cells in immune responses to colorectal cancer. Cancer Immunol Immunother, 2002,51(5):235–247

    Article  CAS  PubMed  Google Scholar 

  24. Spiegel A, Brooks MW, Houshyar S, et al. Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells. Cancer Discov, 2016,6(6):630–649

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Cools-Lartigue J, Spicer J, Mcdonald B, et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Invest, 2013,123(8):3446–3458

    Article  CAS  PubMed Central  Google Scholar 

  26. Chanmee T, Ontong P, Konno K, et al. Tumorassociated macrophages as major players in the tumor microenvironment. Cancers, 2014,6(3):1670–1690

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer, 2011,11(2):123–134

    Article  CAS  PubMed  Google Scholar 

  28. Palumbo JS, Talmage KE, Massari JV, et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood, 2005,105(1):178–185

    Article  CAS  PubMed  Google Scholar 

  29. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet, 2001,357(9255):539–545

    Article  CAS  Google Scholar 

  30. Hara M, Yonei A, Ayabe T, et al. Postoperative serum C-reactive protein levels in non-small cell lung cancer patients. Ann Thorac Cardiovasc Surg, 2010,16(2):85–90

    PubMed  Google Scholar 

  31. Heikkila K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health, 2007,61(9):824–833

    Article  PubMed  PubMed Central  Google Scholar 

  32. Coussens LM, Werb Z. Inflammation and cancer. Nature, 2002,420(6917):860–867

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Nazha B, Moussaly E, Zaarour M, et al. Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate? World J Gastrointest Surg, 2015,7(12):370–377

    Article  PubMed  PubMed Central  Google Scholar 

  34. Li G, Gao J, Liu ZG, et al. Influence of pretreatment ideal body weight percentile and albumin on prognosis of nasopharyngeal carcinoma: Long-term outcomes of 512 patients from a single institution. Head Neck, 2014,36(5):660–666

    Article  PubMed  Google Scholar 

  35. Dan J, Zhang Y, Peng Z, et al. Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation. PLoS One, 2013,8(3):e58184

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology and Biostatistics, the Ministry of Education Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    Zi-quan Zhou, Shuo Pang, Xing-chen Yu, Qi Xue, Hong-yu Jiang & Li Liu

  2. Department of Medical Oncology, Hubei Cancer Hospital, Wuhan, 430079, China

    Xin-jun Liang

Authors
  1. Zi-quan Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shuo Pang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xing-chen Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qi Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hong-yu Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xin-jun Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Li Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xin-jun Liang or Li Liu.

Additional information

This work was supported by the National Natural Science Foundation of China to Li LIU (No. 81302491), the Special Research Funds for Doctoral Programs from Ministry of Education of China to Li LIU (No. 20130142120021), the Fundamental Research Funds for the Central Universities, HUST to Li LIU (No. 2013QN001), and the National Natural Science Foundation of China to Xin-jun LIANG (No. 81572287 and 81772499)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, Zq., Pang, S., Yu, Xc. et al. Predictive Values of Postoperative and Dynamic Changes of Inflammation Indexes in Survival of Patients with Resected Colorectal Cancer. CURR MED SCI 38, 798–808 (2018). https://doi.org/10.1007/s11596-018-1946-6

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-018-1946-6

Key words

Search

Navigation